Latest Diabetes: Type II news
Oral Orforglipron Noninferior, Superior to Oral Semaglutide for T2DM
posted March 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
Semaglutide May Increase Risk for Nonarteritic Anterior Ischemic Optic Neuropathy
posted February 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Maternal Diabetes Linked to Increased Risk for Epilepsy in Offspring
posted February 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
Sodium-Glucose Cotransporter 2 Inhibitors Tied to Lower Use of Gout Medications
posted February 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Outpatient Benzodiazepine Treatment Down in U.S. Adults From 2018 to 2022 
Diltiazem Linked to Increased Risk for Bleeding Complications in A-Fib .jpg)
Health Consequences Vary by Chemo Regimen in Testicular Cancer Survivors 
Perioperative Enfortumab Vedotin + Pembrolizumab Tied to Improved Outcomes With Bladder Cancer Related Articles
Drop in Greenhouse Gas Emissions Seen With Effective Prevention, Management of T2DM 
Surgery Beats Medical Therapy in T2D, Regardless of Social Deprivation 
New Metabolites Associated With Type 2 Diabetes Identified 
Nutritional Guidance Lacking for Adults Receiving Semaglutide, Tirzepatide Monthly Specialist Briefings
Stay Connected
